US Patent Issued to UCB BIOPHARMA on May 26 for "Antibody with binding specificity for human IL-13" (British Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,507, issued on May 26, was assigned to UCB BIOPHARMA SRL (Brussels).

"Antibody with binding specificity for human IL-13" was invented by Daniel John Lightwood (Slough, Great Britain), Ralph Adams (Slough, Great Britain) and Roger Thomas Palframan (Slough, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to antibody molecules having specificity for antigenic determinants of human IL-13, therapeutic uses of the antibody molecules and methods for producing the antibody molecules."

The patent was filed on Dec. 18, 2020, under Application No. 17/787,039.

*For further information, including images, charts and tables, ple...